PCSK9 Prosegment Chimera as Novel Inhibitors of LDLR Degradation

Open Access

Peer-reviewed

Research Article

Yascara Grisel Luna Saavedra,

Affiliation Laboratory of Biochemical Neuroendocrinology, Clinical Research Institute of Montreal, affiliated to the Université de Montréal, Montréal, Québec, Canada
⨯
Jianbing Zhang,

Affiliation Institute for Biological Sciences, National Research Council Canada, Ottawa, Ontario, Canada
⨯
Nabil G. Seidah

* E-mail: seidahn@ircm.qc.ca

Affiliation Laboratory of Biochemical Neuroendocrinology, Clinical Research Institute of Montreal, affiliated to the Université de Montréal, Montréal, Québec, Canada
⨯

Reader Comments (0)

Recombinant proteins
Is the Subject Area "Recombinant proteins" applicable to this article?

Thanks for your feedback.
Transfection
Is the Subject Area "Transfection" applicable to this article?

Thanks for your feedback.
Zymogens
Is the Subject Area "Zymogens" applicable to this article?

Thanks for your feedback.
Immunoprecipitation
Is the Subject Area "Immunoprecipitation" applicable to this article?

Thanks for your feedback.
Enzyme-linked immunoassays
Is the Subject Area "Enzyme-linked immunoassays" applicable to this article?

Thanks for your feedback.
Hypercholesterolemia
Is the Subject Area "Hypercholesterolemia" applicable to this article?

Thanks for your feedback.
Antibodies
Is the Subject Area "Antibodies" applicable to this article?

Thanks for your feedback.
Enzyme inhibitors
Is the Subject Area "Enzyme inhibitors" applicable to this article?

Thanks for your feedback.